GlassScriptPhysician profile
Andrea Tomey
NPI 1528790086
$358.10
in general payments reported to CMS, 2019-2025
15 companies · $39.46 in 2025
The $39.46 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $72.48 · 2023: $142 · 2024: $104 · 2025: $39.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $74.15 | 2022-2024 | Austedo Xr |
| Abbvie INC. | $37.85 | 2022-2024 | |
| Corium, LLC | $33.79 | 2023 | Azstarys |
| Lundbeck LLC | $33.10 | 2022-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $22.75 | 2023 | Rexulti, Abilify Maintena |
| Indivior INC. | $20.66 | 2025 | Sublocade |
| Vertex Pharmaceuticals Incorporated | $18.80 | 2025 | |
| Alkermes, INC. | $18.27 | 2023 | Aristada, Lybalvi |
| Ironshore Pharmaceuticals INC. | $15.25 | 2022 | |
| Lilly USA, LLC | $14.78 | 2024 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $14.39 | 2022 | |
| Exact Sciences Corporation | $14.20 | 2024 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $13.93 | 2023 | Hetlioz, Fanapt |
| E.R. Squibb & Sons, L.L.C. | $13.11 | 2024 | Cobenfy |
| Neurocrine Biosciences, INC. | $13.07 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Tomey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.